---
title: "Here’s How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Years"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299211458.md"
description: "Merck & Co (NYSE:MRK) has outperformed the market over the past five years with an annualized return of 14.92%, exceeding the market by 3.02%. With a market capitalization of $355.77 billion, a hypothetical $100 investment made five years ago would now be worth $200.54, illustrating the power of compounded returns."
datetime: "2026-09-16T16:17:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299211458.md)
  - [en](https://longbridge.com/en/news/299211458.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299211458.md)
generator: "portal-rs"
---

# Here’s How Much You Would Have Made Owning Merck & Co Stock In The Last 5 Years

Merck & Co (NYSE:MRK) has outperformed the market over the past 5 years by 3.02% on an annualized basis producing an average annual return of 14.92%. Currently, Merck & Co has a market capitalization of $355.77 billion.

**Buying $100 In MRK:** If an investor had bought $100 of MRK stock 5 years ago, it would be worth **$200.54** today based on a price of $144.20 for MRK at the time of writing.

### Merck & Co’s Performance Over Last 5 Years

![comp_fig](https://imageproxy.pbkrs.com/https://cdn.benzinga.com/files/images/story/2026/09/16/9cd7d9d7d2ff8a0d6feea13eb1fa1be9.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg)

Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

*This article was generated by Benzinga's automated content engine and reviewed by an editor.*

### Related Stocks

- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [What Is Merck (MRK) Betting On With Its $2.13 Billion KRAS Deal?](https://longbridge.com/en/news/300416193.md)
- [Merck's experimental eye drug meets goal in trial, but raises safety concerns](https://longbridge.com/en/news/301512275.md)
- [Oracle Stocks Edge Up as $1 Billion Backs AI Partners](https://longbridge.com/en/news/302919901.md)
- [Memory Stocks Are Plummetting. Jensen Huang Says the Bears Have It Wrong.](https://longbridge.com/en/news/302948213.md)
- [IREN Stock: Why Analysts Still See Over 200% Upside Despite This Week's Plunge](https://longbridge.com/en/news/302922686.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**